Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1996
03/21/1996WO1996004382A3 Secreted viral proteins useful for vaccines and diagnostics
03/21/1996CA2200087A1 Active induction or passive immunization of anti-gp48 antibodies and isolated gp48 protein
03/21/1996CA2200085A1 Control of hair growth
03/21/1996CA2199939A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996CA2199721A1 Pharmaceutical compositions containing d2o
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/20/1996EP0702085A1 Recombinant infectious non-segmented negative strand RNA virus
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701696A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
03/20/1996EP0701612A1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
03/20/1996EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
03/20/1996EP0701604A1 Immortalization of denditric cells with v-myc oncogene
03/20/1996EP0701573A1 Genetically engineered immunoglobulins
03/20/1996EP0701572A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0489072B1 Treatment of chronic inflammatory conditions
03/20/1996EP0456686B1 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation
03/20/1996EP0401347B1 Use of transferrin to combat the toxic effects of endotoxins in endotoxemia
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/19/1996US5500366 Polynucleotide encoding T-cell epitopes of the protein TraT
03/19/1996US5500362 Chimeric antibody with specificity to human B cell surface antigen
03/19/1996US5500355 Used for diagnosis of retroviral diseases
03/19/1996US5500215 Immunology
03/19/1996CA2073012C Method for isolating factor viii
03/17/1996CA2158395A1 Coccidiosis poultry vaccine
03/14/1996WO1996007915A1 Predictive test for hepatitis-b resistance
03/14/1996WO1996007745A2 Mycobacteria functional screening and/or expression vectors
03/14/1996WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007433A1 Gene therapy drug for cancer, medicinal composition, and therapeutic method
03/14/1996WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996WO1996007429A1 Liquid immunoglobulin formulations
03/14/1996WO1996007428A1 Peptide compositions capable of down regulating an antigen specific immune response
03/14/1996WO1996007427A1 Capsular polysaccharide immunomodulator
03/14/1996WO1996007426A1 Enteral vaccine for vaginal infections
03/14/1996WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
03/14/1996WO1996002264A3 Chlorine dioxide-containing compositions for use in the eye
03/14/1996WO1996001615A3 Hepatitis a virus deletion mutants and vaccine formulations containing the same
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199255A1 Enteral vaccine for vaginal infections
03/14/1996CA2198869A1 Peptide compositions capable of down regulating an antigen specific immune response
03/14/1996CA2198707A1 Predictive test for hepatitis-b resistance
03/14/1996CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996CA2197888A1 Modified human c3 proteins
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/13/1996EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
03/13/1996EP0700992A1 Method of cultivation, attenuation of virulence and the in vitro cloning of the genus Babesia and their applications
03/13/1996EP0700991A1 Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
03/13/1996EP0700446A1 Antibodies specific for dcc gene product
03/13/1996EP0700445A1 Stress proteins and uses therefor
03/13/1996EP0700444A1 Immunotoxins comprising gelonin and an antibody
03/13/1996EP0700441A1 Multiple sclerosis virus
03/13/1996EP0700440A1 Regulator of contact-mediated hemolysin
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700402A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/13/1996EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
03/13/1996EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
03/13/1996EP0700297A1 Surrogate tolerogenesis for the development of tolerance to xenografts
03/13/1996EP0491007B1 Structural alterations of the egf receptor gene in human gliomas
03/13/1996EP0438497B1 Vasopermeability-enhancing conjugates
03/13/1996EP0436598B1 Cell sorting technique and applications thereof
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996EP0428602B1 Polypeptides and dna encoding same
03/13/1996CN1118574A Immunotherapeutic composition
03/13/1996CN1118573A Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
03/13/1996CN1118271A Extraction of allergen of intracellular Mycobacterium
03/12/1996US5498499 Peptides and antibodies that inhibit platelet adhesion
03/12/1996US5498414 Attenuated strains of Aeromonas salmonicida useful as fish vaccines
03/12/1996US5498413 Recombinant subunit vaccine against porcine parvovirus
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006934A1 Infectious peritonitis vaccine
03/07/1996WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy
03/07/1996WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
03/07/1996WO1996006638A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant
03/07/1996WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1996003506A3 Analog of haemophilus hin47 with reduced protease activity
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/07/1996WO1995022561A3 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
03/07/1996WO1995019777A3 Use of diesters of muramyl peptides in oral form as immunostimulating agents
03/07/1996CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides
03/07/1996CA2198479A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
1 ... 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 ... 1823